SMOLDERING MULTIPLE MYELOMA (SMM)
Clinical trials for SMOLDERING MULTIPLE MYELOMA (SMM) explained in plain language.
Never miss a new study
Get alerted when new SMOLDERING MULTIPLE MYELOMA (SMM) trials appear
Sign up with your email to follow new studies for SMOLDERING MULTIPLE MYELOMA (SMM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to stop precancerous condition from turning into cancer
Prevention OngoingThis study is testing an investigational drug called linvoseltamab in people diagnosed with high-risk smoldering multiple myeloma (SMM), a condition that often progresses to active multiple myeloma. The main goals are to see if the drug is safe and if it can eliminate the abnorma…
Matched conditions: SMOLDERING MULTIPLE MYELOMA (SMM)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Prevention
Last updated Mar 20, 2026 14:47 UTC
-
Scientists hunt blood clues to stop cancer before it strikes
Knowledge-focused OngoingThis study aims to find biological markers that can predict when early, symptom-free blood conditions (MGUS and SMM) will progress to the cancer multiple myeloma. Researchers will analyze blood, bone marrow, and mouth bacteria samples from 60 patients to understand the biological…
Matched conditions: SMOLDERING MULTIPLE MYELOMA (SMM)
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:25 UTC